K-RAS VAL-12 Mutant Protein

**Semantic type:** Amino Acid, Peptide, or Protein|Immunologic Factor

**Definition:** A synthetic form of the K-ras protein containing a point mutation at position 12 (glycine to valine). Vaccines using mutant K-ras proteins may be used in the immunotherapy of various cancers that express mutated K-ras proteins. (NCI04)